This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Pfizer's Modified mRNA Influenza Vaccine
Ticker(s): PFEWho's the expert?
Institution: University of Michigan
- Co-Director, Michigan Center for Respiratory Virus Research and Response and Chair of the FDA's Vaccines and Related Biological Products Advisory Committee
- Emeritus Professor, Epidemiology & Professor, Global Public Health at University of Michigan
- Research focused on occurrence, prevention, and control of respiratory infections. International expert on pandemic planning and emergency response to respiratory virus outbreaks including Hong Kong influenza, avian influenza, and SARS
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
